vs
Electromed, Inc.（ELMD）与FONAR CORP（FONR）财务数据对比。点击上方公司名可切换其他公司
FONAR CORP的季度营收约是Electromed, Inc.的1.4倍（$25.5M vs $18.9M）。Electromed, Inc.净利率更高（14.6% vs 8.0%，领先6.6%）。Electromed, Inc.同比增速更快（16.3% vs 2.4%）。Electromed, Inc.自由现金流更多（$2.4M vs $-227.0K）。过去两年Electromed, Inc.的营收复合增速更高（16.7% vs -0.3%）
Electromed, Inc.是一家专注于呼吸护理设备研发、生产与销售的医疗设备企业，核心产品为高频胸壁振荡排痰系统，主要服务美国市场的家庭护理及临床医疗机构，为囊性纤维化、慢阻肺等呼吸系统疾病患者提供气道清理解决方案。
FONAR是一家专业医疗技术企业，专注于设计、制造及销售包括立式、开放式在内的创新磁共振成像（MRI）设备，主要服务美国的医院、影像诊断中心及医疗机构，为临床诊断提供高精度扫描解决方案。
ELMD vs FONR — 直观对比
营收规模更大
FONR
是对方的1.4倍
$18.9M
营收增速更快
ELMD
高出13.9%
2.4%
净利率更高
ELMD
高出6.6%
8.0%
自由现金流更多
ELMD
多$2.6M
$-227.0K
两年增速更快
ELMD
近两年复合增速
-0.3%
损益表 — Q2 2026 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $18.9M | $25.5M |
| 净利润 | $2.8M | $2.1M |
| 毛利率 | 78.4% | — |
| 营业利润率 | 19.2% | 13.5% |
| 净利率 | 14.6% | 8.0% |
| 营收同比 | 16.3% | 2.4% |
| 净利润同比 | 40.3% | 4.7% |
| 每股收益（稀释后） | $0.32 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELMDFONR
| Q4 25 | $18.9M | $25.5M | ||
| Q3 25 | $16.9M | $26.0M | ||
| Q2 25 | $17.4M | $27.3M | ||
| Q1 25 | $15.7M | $27.2M | ||
| Q4 24 | $16.3M | $24.9M | ||
| Q3 24 | $14.7M | $25.0M | ||
| Q2 24 | $14.8M | $25.9M | ||
| Q1 24 | $13.9M | $25.7M |
净利润ELMDFONR
| Q4 25 | $2.8M | $2.1M | ||
| Q3 25 | $2.1M | $2.3M | ||
| Q2 25 | $2.2M | $729.3K | ||
| Q1 25 | $1.9M | $2.5M | ||
| Q4 24 | $2.0M | $2.0M | ||
| Q3 24 | $1.5M | $3.1M | ||
| Q2 24 | $1.8M | $830.4K | ||
| Q1 24 | $1.5M | $1.9M |
毛利率ELMDFONR
| Q4 25 | 78.4% | — | ||
| Q3 25 | 78.1% | — | ||
| Q2 25 | 78.3% | — | ||
| Q1 25 | 78.0% | — | ||
| Q4 24 | 77.7% | — | ||
| Q3 24 | 78.3% | — | ||
| Q2 24 | 76.2% | — | ||
| Q1 24 | 74.8% | — |
营业利润率ELMDFONR
| Q4 25 | 19.2% | 13.5% | ||
| Q3 25 | 15.8% | 14.1% | ||
| Q2 25 | 17.5% | 5.3% | ||
| Q1 25 | 13.6% | 15.2% | ||
| Q4 24 | 15.6% | 11.9% | ||
| Q3 24 | 13.2% | 21.0% | ||
| Q2 24 | 15.7% | 7.4% | ||
| Q1 24 | 13.3% | 16.8% |
净利率ELMDFONR
| Q4 25 | 14.6% | 8.0% | ||
| Q3 25 | 12.6% | 8.7% | ||
| Q2 25 | 12.7% | 2.7% | ||
| Q1 25 | 12.1% | 9.2% | ||
| Q4 24 | 12.1% | 7.9% | ||
| Q3 24 | 10.0% | 12.6% | ||
| Q2 24 | 12.3% | 3.2% | ||
| Q1 24 | 10.8% | 7.3% |
每股收益（稀释后）ELMDFONR
| Q4 25 | $0.32 | — | ||
| Q3 25 | $0.25 | — | ||
| Q2 25 | $0.26 | — | ||
| Q1 25 | $0.21 | — | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $0.16 | — | ||
| Q2 24 | $0.20 | — | ||
| Q1 24 | $0.17 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.8M | $121.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $45.4M | $176.9M |
| 总资产 | $54.9M | $217.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ELMDFONR
| Q4 25 | $13.8M | $121.0K | ||
| Q3 25 | $14.1M | $122.0K | ||
| Q2 25 | $15.3M | $56.5M | ||
| Q1 25 | $15.2M | $123.0K | ||
| Q4 24 | $16.2M | $121.0K | ||
| Q3 24 | $13.9M | $136.0K | ||
| Q2 24 | $16.1M | $56.5M | ||
| Q1 24 | $11.7M | $134.0K |
总债务ELMDFONR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $66.9K | ||
| Q1 24 | — | — |
股东权益ELMDFONR
| Q4 25 | $45.4M | $176.9M | ||
| Q3 25 | $44.7M | $174.9M | ||
| Q2 25 | $43.2M | $172.6M | ||
| Q1 25 | $43.9M | $171.9M | ||
| Q4 24 | $43.6M | $169.8M | ||
| Q3 24 | $41.5M | $168.7M | ||
| Q2 24 | $44.5M | $166.0M | ||
| Q1 24 | $42.5M | $165.8M |
总资产ELMDFONR
| Q4 25 | $54.9M | $217.2M | ||
| Q3 25 | $53.6M | $218.4M | ||
| Q2 25 | $53.8M | $216.9M | ||
| Q1 25 | $52.5M | $214.9M | ||
| Q4 24 | $52.3M | $208.0M | ||
| Q3 24 | $48.9M | $212.3M | ||
| Q2 24 | $52.2M | $214.2M | ||
| Q1 24 | $48.9M | $209.6M |
负债/权益比ELMDFONR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0M | $171.0K |
| 自由现金流经营现金流 - 资本支出 | $2.4M | $-227.0K |
| 自由现金流率自由现金流/营收 | 12.7% | -0.9% |
| 资本支出强度资本支出/营收 | 3.4% | 1.6% |
| 现金转化率经营现金流/净利润 | 1.10× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $7.9M | $5.7M |
8季度趋势，按日历期对齐
经营现金流ELMDFONR
| Q4 25 | $3.0M | $171.0K | ||
| Q3 25 | $169.0K | $1.7M | ||
| Q2 25 | $3.9M | $4.2M | ||
| Q1 25 | $2.1M | $3.1M | ||
| Q4 24 | $3.2M | $2.2M | ||
| Q3 24 | $2.3M | $1.7M | ||
| Q2 24 | $4.5M | $4.6M | ||
| Q1 24 | $1.4M | $2.8M |
自由现金流ELMDFONR
| Q4 25 | $2.4M | $-227.0K | ||
| Q3 25 | $-83.0K | $-177.0K | ||
| Q2 25 | $3.7M | $3.6M | ||
| Q1 25 | $1.9M | $2.6M | ||
| Q4 24 | $2.9M | $1.5M | ||
| Q3 24 | $2.3M | $-148.0K | ||
| Q2 24 | $4.5M | $4.2M | ||
| Q1 24 | $1.3M | $2.6M |
自由现金流率ELMDFONR
| Q4 25 | 12.7% | -0.9% | ||
| Q3 25 | -0.5% | -0.7% | ||
| Q2 25 | 21.4% | 13.1% | ||
| Q1 25 | 12.2% | 9.4% | ||
| Q4 24 | 18.0% | 6.0% | ||
| Q3 24 | 15.5% | -0.6% | ||
| Q2 24 | 30.1% | 16.1% | ||
| Q1 24 | 9.1% | 10.2% |
资本支出强度ELMDFONR
| Q4 25 | 3.4% | 1.6% | ||
| Q3 25 | 1.5% | 7.2% | ||
| Q2 25 | 0.8% | 2.4% | ||
| Q1 25 | 1.0% | 2.2% | ||
| Q4 24 | 1.4% | 3.0% | ||
| Q3 24 | 0.3% | 7.2% | ||
| Q2 24 | 0.1% | 1.6% | ||
| Q1 24 | 0.6% | 0.7% |
现金转化率ELMDFONR
| Q4 25 | 1.10× | 0.08× | ||
| Q3 25 | 0.08× | 0.75× | ||
| Q2 25 | 1.75× | 5.79× | ||
| Q1 25 | 1.10× | 1.26× | ||
| Q4 24 | 1.60× | 1.14× | ||
| Q3 24 | 1.57× | 0.53× | ||
| Q2 24 | 2.46× | 5.54× | ||
| Q1 24 | 0.90× | 1.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELMD
暂无分部数据
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
